Showing 1 - 2 results of 2 for search 'P. Neven', query time: 0.02s Refine Results
  1. 1
    Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant

    Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant by P. Neven, P. A. Fasching, S. Chia, G. Jerusalem, M. De Laurentiis, S.-A. Im, K. Petrakova, G. V. Bianchi, M. Martín, A. Nusch, G. S. Sonke, L. De la Cruz-Merino, J. T. Beck, J. P. Zarate, Y. Wang, A. Chakravartty, C. Wang, D. J. Slamon

    Published 2023-08-01
    Get full text
    Article
  2. 2
    P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outcomes

    P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4... by S. Johnston, M. Toi, J. O’Shaughnessy, P. Rastogi, M. Campone, P. Neven, C.S. Huang, J. Huober, G. Garnica Jaliffe, I. Cicin, S. Tolaney, M.P. Goetz, H. Rugo, E. Senkus, L. Testa, L. Del Mastro, C. Shimizu, R. Wei, A. Shahir, M. Munoz, B. San Antonio, V. Andre, N. Harbeck, M. Martín

    Published 2023-03-01
    Get full text
    Article

Search Tools: